Nonagen Bioscience, a cancer diagnostics company, announced CE marking for its Oncuria immunoassay for bladder cancer.
Oncuria is the first-of-its-kind multiplex urine test for the...
Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value...
Nordic Bioscience, a growing biomarker company, announced the strengthening of its ongoing collaboration with Roche Diagnostics for the development of proprietary biomarkers involved in...
Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of...
Hansa Biopharma, "Hansa", pioneer in enzyme technology for rare immunological conditions, announces the recommendation by the National Institute for Health and Care Excellence (NICE)...
